NEWS ON HEALTH CARE
-
January 30, 2023, Monday
Sun Pharma nears 52-week high ahead of Q3 results; stock up 7% in a month
In the past one month, Sun Pharma outperformed market as shares surged 7 per cent, as compared to 2.5 per cent decline in the S&P BSE Sensex
-
January 30, 2023, Monday
Enzene Biosciences raises $50 million, aims to expand into global markets
Enzene said it has built a highly experienced 400-person team under the leadership of Dr. Himanshu Gadgil, CEO at Enzene Biosciences Ltd
-
January 27, 2023, Friday
Flows to Indian equities are at risk as investors eye China: Chris Wood
He believes India remains the best long-term equity story in Asian and the emerging market (EM) context
-
January 25, 2023, Wednesday
Torrent Pharma Q3 PAT up 14% to Rs 249 crore riding on India, Brazil
Torrent Pharma's revenues came in at Rs 2,491 crore for the quarter under review. The Ebitda margins were at 29.1 per cent while gross margins ...
-
January 25, 2023, Wednesday
DRL posts strong 77% profit growth to Rs 1,247 cr riding on US, Russia
Firm says sustained focus on improving productivity has also helped boost profits; DRL is now bullish on its biosimilars and hopes to start ...
-
January 25, 2023, Wednesday
Torrent Pharma Q3 net profit up 14% to Rs 283 cr; interim dividend declared
Torrent Pharma on Wednesday said its consolidated net profit increased by 14 per cent to Rs 283 crore in the third quarter ended December 31, ...
-
January 25, 2023, Wednesday
Cipla Q3 net up 10% to Rs 801 cr, posts highest ever quarterly sales in US
Revenue up 6% to Rs 5,810 cr; firm expects US FDA audit at Goa unit
-
January 24, 2023, Tuesday
Lupin Digital launches Lyfe, a 24x7 monitoring ecosystem for heart patients
Company aims to onboard one million patients the platform, which aims to help them improve heart health through doctor-connected online and ...
-
January 19, 2023, Thursday
Sun Pharma to acquire US-based Concert Pharmaceuticals for $576 million
Deal size could expand to $827 mn if additional milestone-based payments are made
-
January 18, 2023, Wednesday
Cipla launches diagnostic device, says it will provide results in minutes
Cippoint offers parameters to test for cardiac markers, diabetes, infectious diseases, fertility
-
January 17, 2023, Tuesday
Lupin gets USFDA tentative nod for generic drugs to treat HIV infection
Pharmaceutical firm Lupin on Monday said it has received tentative approval from the US health regulator to market its generic version of ...
-
January 15, 2023, Sunday
Breather for Natco in Novartis cardiac drug case from Delhi High Court
May open floodgates for Indian drugmakers to launch the generic version of the drug as early as next week
-
January 10, 2023, Tuesday
RIL, Dr Reddy's Labs: 5 Nifty500 stocks cross 200-DMA, defying weak trend
Following a strong close over the 200-DMA set at Rs 2,559, the chart structure of Reliance Industries reveals a "Double Bottom" breakout
-
January 10, 2023, Tuesday
Mehul Kothari recommends to buy Laurus Labs, RateGain Travel Technologies
According to the technical analyst from Anand Rathi, Laurus Labs can rally to Rs 400; while RateGain can jump to Rs 330.
-
January 06, 2023, Friday
F&O Call: Nandish Shah recommends to long Glenmark Pharma futures
The derivative analyst from HDFC Securities expects Glenmark Pharma January futues to test Rs 450 on the upside.
-
January 05, 2023, Thursday
Pfizer announces 12-week paternity leave policy for its employees
The policy that came into effect on January 1, 2023, gives biological and adoptive fathers the option to take leaves in up to four tranches
-
January 03, 2023, Tuesday
Granules forges strategic partnership with Greenko ZeroC for Kakinada plant
Under the collaboration, Greenko ZeroC will be supplying carbon free energy and enable green hydrogen along with its various chemical
-
December 30, 2022, Friday
Stocks to Watch: Elin Electronics, Cipla, Eicher Motors, RIL, Banks, Pharma
Stocks to Watch: Elin Electronics to debut today, the stock is likely to list on a quiet note.
-
December 27, 2022, Tuesday
Stocks to Watch: NTPC, LIC Housing, Alembic Pharma, SIS, Gail, Puravankara
Stocks to Watch: In the F&O space, Punjab National Bank (PNB) is the only stock in ban period on Tuesday.
-
December 26, 2022, Monday
Alembic Pharma gets USFDA nod for generic drug to treat breast cancer
Alembic Pharmaceuticals on Monday said it has received final approval from the US health regulator for its generic Fulvestrant injection used in ...
-
December 26, 2022, Monday
Stocks to Watch: Suven Pharma, Telecom, Restaurant, Travel, DLF, Tata Power
Stocks to Watch: Shares of restaurant and travel related firms are likely to be in foucs as government ups the ante to keep the new variant of ...
-
December 23, 2022, Friday
Pharma stocks upbeat amid Covid-19 scare; Divi's, Lupin can gain up to 10%
Technically, the Nifty Pharma index needs to immediate hurdle at 13,500, for further upside to 14,250.
-
December 23, 2022, Friday
Stock of this PSU pharma company has zoomed 61% in 3 days on heavy volumes
The stock was locked in the 20% upper circuit; around 1.4 million shares, representing 3.2 per cent of total equity of the pharmaceutical ...
-
December 23, 2022, Friday
Mehul Kothari recommends Biocon, Aurobindo Pharma for trading gains
According to the technical analyst from Anand Rathi, Aurobindo Pharma can rally to Rs 490; while Biocon can jump to Rs 295.
-
December 23, 2022, Friday
Stocks to Watch: Aban Holdings, Landmark Cars, RIL, Lupin, Gail, JK Cement
Stocks to Watch Aban Holdings and Landmak Cars will be debuting on the stock exchanges on Friday. Both these stocks are likely to witness a ...
-
December 23, 2022, Friday
Lupin Pharma's US-based arm recalls blood pressure tablets in US market
Pharmaceuticals firm Lupin Ltd on Thursday said its US-based arm is recalling four lots of Quinapril tablets used to treat high blood pressure ...
-
December 22, 2022, Thursday
Lupin set to gain market share in US flu season; shares up 6% in 2 sessions
The stock has underperformed peers and the benchmark over the past year
-
December 22, 2022, Thursday
Thyrocare surges 26% in two days amid fresh Covid-19 scare
Thyrocare is diagnostic chains that conduct an array of medical diagnostic tests and profiles of tests that centre on early detection and ...
-
December 22, 2022, Thursday
Stocks to Watch: Sula Vineyards, RIL, Spandana, Speciality Restaurants
Stocks to Watch Today: Shares of Sula Vineyards likely to list on a tepid note on Thursday.
-
December 21, 2022, Wednesday
Glenmark Pharma launches combination drug for Type 2 diabetic patients
Glenmark Pharmaceuticals Ltd on Wednesday said it has launched triple fixed-dose combination Teneligliptin with Pioglitazone and Metformin in ...
-
December 21, 2022, Wednesday
Healthcare stocks rally up to 8% as Covid cases spurt in China, Japan
Reports suggest that Union Health Minister Mansukh Mandaviya will review the Covid-19 pandemic situation, in view of a spurt in COVID-19 cases ...
-
December 13, 2022, Tuesday
Fosun's sale of Gland Pharma to become India's biggest pharma deal: Report
With the acquisition, Gland pharma may also get access to global companies like AstraZeneca, Sanofi, Mylan, and Organon
-
December 09, 2022, Friday
Podcast: Will Viatris deal inject fresh momentum into Biocon biz?
Sohini Das caught up with Biocon Biologics CEO Shreehas Tambe to know more about the deal and the company's future plans
-
December 08, 2022, Thursday
Sun Pharmaceuticals' Halol plant gets 'import alert' from USFDA
The USFDA had imposed an import ban on the Halol plant in December 2015 too
-
December 08, 2022, Thursday
Sun Pharma slips nearly 4% as USFDA issues import alert on Halol facility
For the year ended March 31, 2022, supplies to the US market from the Halol facility accounted for approximately 3 per cent of the company's ...
-
December 02, 2022, Friday
Orchid Pharma board approves QIP programme to raise Rs 500 crore
Drug firm Orchid Pharma on Thursday said its board has approved to raise Rs 500 crore from institutional investors. The company's board has ...
-
December 01, 2022, Thursday
Stocks to Watch: TCS, KPI Green, Siemens, Alstom India, Apollo Hospitals
Stocks to Watch Today: In the F&O space, BHEL, Delta Corp, Indiabulls Housing Finance and PNB are the stocks in ban period on Thursday.
-
November 30, 2022, Wednesday
Gland Pharma stock seen underperforming after acquiring France's Cenexi
Lack of near-term visibility on profitability for the core business is another concern about Indian firm
-
November 30, 2022, Wednesday
Gland Pharma enters into agreement to acquire Cenexi; stock slips 5%
The acquisition provides Gland Pharma access to leading know-how and development capabilities in sterile forms including for ophthalmic gel, ...
-
November 30, 2022, Wednesday
Stocks to Watch: Zomato, SBI, Adani Group, Britannia, ONGC, Gland Pharma
Stocks to Watch Today: According to reports, Zomato is likely to witness a block deal on Wednesday.
-
November 29, 2022, Tuesday
Laurus Labs hits 52-week low, tanks 7% on margin concerns
Laurus has witnessed severe pricing pressure and lower volumes in its ARV formulations portfolio for five quarters now, resulting in significant ...
